4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-14-000126
Chief Scientific Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Radvanyi Laszlo · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-06-23 | Grant or award : show line 1 in the form | +180,000 | 180,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-06-23 | Grant or award : show line 2 in the form Stock Option (right to buy) | +180,000 | $5.80 | 2024-06-22 | 180,000 | 180,000 | D |
Loading xslF345X03/primary_doc.xml…